Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £16.31m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Directorate Change

17 Dec 2021 07:00

RNS Number : 9380V
Mission Group PLC (The)
17 December 2021
Β 

17 December 2021

THEΒ MISSION GROUP plc

Β 

("MISSION", "the Group")Β 

Β 

Appointment of Non-Executive Director

TheΒ MISSIONΒ Group plcΒ (AIM: TMG), creator ofΒ Work ThatΒ CountsΒ comprising a network of 16 Agencies delivering real, sustainable growth for its Clients, is pleased to announce that is has appointed Dr Eliza Filby as a Non-Executive Director, effective 1 January 2022.

Dr Eliza Filby is a 'Generational Intelligence' expert with a longstanding career in helping businesses understand generational shifts within politics, society and the workplace.Β Her experience involves consulting with a large range of companies and organisations including Warner Brothers, HSBC, the Ministry of Defence and the Royal Household.

Β 

Dr Filby will replace Non-Executive Director Andrew Nash as Chair of the Company's Remuneration Committee on appointment. Andrew will take over the role Senior Independent Director and will Chair MISSION's Audit and Risk Committee.

James Clifton, Chief Executive ofΒ TheΒ MISSION Group plc, commented:Β "We are very excited to have Dr Filby on board. She has unique specialist expertise on generational differences and trends, which is highly relevant and valuable to much of the work MISSION does for Clients seeking to better understand their consumers. As well as extensive experience advising blue-chip corporates and government bodies, Dr Filby is a regular speaker at major business events such as the Financial Times CEO Forum. A published author, Dr Filby has also led and authored several reports and projects into the future of workplace dynamics and demographic trends."

Β 

Dr Eliza Filby added: "I am thrilled to be joining The MISSION Group and working with James and the team. It is a fantastic business and I look forward to supporting it through its future growth journey."

Β 

ENQUIRIES:

James Clifton, Chief Executive Officer

GilesΒ Lee, Chief Financial Officer

TheΒ MISSIONΒ Group plc

Β 

Β 

020 7462 1415

Β 

Β 

Mark PercyΒ /Β James ThomasΒ /Β Fiona Conroy

Shore Capital (Nomad and Broker)

020 7408 4090

Β 

Β 

Β 

Kate HoareΒ /Β Laura Stewart

HOUSTONΒ (Financial PR and Investor Relations)

0204 529 0549

Β 

NOTES TO EDITORS

Β 

MISSIONΒ is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit.Β Employing 1,000 people across 27 locations and 3 continents, the Group successfully combines its diverse expertise to produceΒ Work ThatΒ CountsΒ for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands.Β www.themission.co.uk

Β 

Regulatory disclosuresΒ (in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies)

Save for the information set out above and below, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Dr Elizabeth Rosana Filby, aged 40.

Dr Filby holds the following current directorships

Eliza Filby Associates Ltd

Filbyproductions Ltd

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAEQLFFFLLBFBL
Date   Source Headline
27th Sep 20227:00 amRNSCHANGES TO THE BOARD
26th Aug 202210:27 amRNSHolding(s) in Company
18th Aug 202210:30 amRNSEBT Share Dealing
17th Aug 20228:45 amRNSEBT Share Dealing
15th Aug 20222:29 pmRNSEBT Share Dealing
12th Aug 20227:00 amRNSEBT Share Dealing
10th Aug 20229:00 amRNSEBT Share Dealing
8th Aug 20228:51 amRNSEBT Share Dealing
5th Aug 20229:36 amRNSEBT Share Dealing
3rd Aug 20227:00 amRNSEBT Share Dealing
25th Jul 20223:47 pmRNSEBT Share Dealing
20th Jul 20228:22 amRNSEBT Share Dealing
19th Jul 20227:00 amRNSEBT Share Purchase
15th Jul 202210:22 amRNSEBT Share Purchase
14th Jul 20229:34 amRNSEBT Share Dealing
13th Jul 20227:00 amRNSTrading Update
8th Jul 20229:02 amRNSEBT Share Dealing
5th Jul 20223:44 pmRNSEBT Share Dealing
30th Jun 20228:55 amRNSEBT Share Dealing
29th Jun 202211:54 amRNSEBT Share Dealing
21st Jun 20222:35 pmRNSResult of AGM
17th Jun 20227:00 amRNSEBT Share Dealing
16th Jun 20227:00 amRNSEBT Share Dealing
15th Jun 20227:00 amRNSEBT Share Dealing
14th Jun 20227:00 amRNSEBT Share Dealing
13th Jun 20227:00 amRNSEBT Share Dealing
10th Jun 20227:00 amRNSEBT Share Dealing
9th Jun 20227:00 amRNSEBT Share Dealing
1st Jun 20228:46 amRNSEBT Share Dealing
31st May 20227:00 amRNSEBT Share Dealing
24th May 202210:48 amRNSEBT Share Dealing
23rd May 20227:00 amRNSEBT Share Dealing
20th May 20227:00 amRNSEBT Share Dealing
19th May 20227:00 amRNSEBT Share Dealing
18th May 20227:00 amRNSEBT Share Dealing
17th May 20227:00 amRNSEBT Share Dealing
16th May 20227:00 amRNSEBT Share Dealing
12th May 20222:36 pmRNSEBT Share Dealing
20th Apr 20229:04 amRNSDirector Dealing
30th Mar 20227:00 amRNSDividend Timetable
29th Mar 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
28th Feb 20227:00 amRNSACQUISITION OF LIVITY
19th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
10th Jan 20221:54 pmRNSHolding(s) in Company
5th Jan 202210:07 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:16 amRNSHolding(s) in Company
25th Oct 20214:49 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSAcquisition of Soul and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.